CRP and rheumatoid arthritis: A small peptide asp-phe and lipid LPE (18:1) were significantly increased in the DAS28-CRP high disease activity (HIGH) group compared with the R-L group (p < 0.05, AUC > 0.7), indicating their potential role as biomarkers in RA disease activity stratification (Fig. 5B).